CD36 and renal cell carcinoma: Interestingly, we observed several proteins robustly detected in RCC-derived CD45+ cells, but not NAT-derived CD45+ cells including CD36, CXCL8 and VAV1, further supporting a disparate activated immune profile associated with of CD45+ cells in RCC tissues relative to CD45+ cells in NATs.